A growing number of companies have chosen a different goal. They see their bottom line as something radically different. Delighting their customers through continuous innovation has become their bottom line. Making money is the result, not the goal, of their activities. The interesting thing is that when they operate this way, they make a lot more money than companies that focus directly on making money.
I feel like these should be moved to the is Dexcom imploding or being run by Dr evil? Thread
Pure realism and idealism will seldom agree. Fortunately, most of us reside somewhere between those polar philosophies. I tend toward the idealistic side since I believe many of the improvements we enjoy in modern life were conceived and inspired by idealism. Dreamers are idealists.
Having said that, I fully realize that a great idea is often best implemented by people who are more realistic. I expect that companies like Dexcom will primarily focus on the bottom line. I don’t accept, however, that giving due consideration to other bottom lines, like their customers, employees or the environment necessarily detracts from their central profit motivation.
The most accurate meter (9.83 MARD*, as I recall) is the Contour Next One. Unfortunately, they have not kept current with Bluetooth, so the only way to load readings is via USB, which you can do on a cellular phone (Android, at least ) if you install the Glooko app. (* Mean Absolute Relative Difference)
The Contour Next One’s low MARD is important because CGMs have to use an example of Bayesian statistics, in that its readings are a two-stage process: In the G5, it’s 20 percents (forget the points part of the rule for now) of the meter reading. Therefore, the final reading has an error range of the 20% meter error range. This explains the increased inaccuracy of the G6 since its reading allows up to 30% of the meter’s accuracy range. (FYI, the reason G6 had to use 30% was an FDA insistence based on its 30% maximum allowance for glucose meters to accommodate those D6 users who use codes rather than blood calibrations.)
I wonder if they will let Type2 ‘s on injectable drugs use this when it comes out. My insurance/ Medicare has me on the Onetouch Reveal AP. I do like it. Since they won’t pay for anything else. Nancy50